Fayez Sarofim & Co
MET icon

Fayez Sarofim & Co’s MetLife MET Stock Holding History

Fayez Sarofim & Co’s Portfolio MET Stock Details MET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-3,830
Closed -$217K – 292
2023
Q2 		$217K Sell
3,830
-5,949
-61% -$330K ﹤0.01% 272
2023
Q1 		$567K Sell
9,779
-592
-6% -$40K ﹤0.01% 204
2022
Q4 		$751K Hold
10,371
– – ﹤0.01% 188
2022
Q3 		$631K Sell
10,371
-1,782
-15% -$114K ﹤0.01% 200
2022
Q2 		$763K Sell
12,153
-1,966
-14% -$130K ﹤0.01% 201
2022
Q1 		$992K Sell
14,119
-10,049
-42% -$679K ﹤0.01% 200
2021
Q4 		$1.51M Buy
24,168
+13,074
+118% +$821K ﹤0.01% 176
2021
Q3 		$685K Sell
11,094
-18,332
-62% -$1.1M ﹤0.01% 223
2021
Q2 		$1.76M Buy
+29,426
New +$1.86M 0.01% 166

Other funds holding MET

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Fayez Sarofim & Co's MET Position: Q3 2023 in Review

Fayez Sarofim & Co sold out of MetLife (MET) in Q3 2023, closing a stake of 3,830 shares — an estimated $217K sold.

Fayez Sarofim & Co first reported a position in MET in Q2 2021 and held it in 9 quarters. The position peaked at $1.76M in Q2 2021. 1,182 funds tracked by Wall St. Rank hold MET as of Q3 2023.

  • Fayez Sarofim & Co reported no remaining MetLife position as of Q3 2023 after selling out during the quarter.
  • Fayez Sarofim & Co sold 3,830 MetLife shares in Q3 2023, an estimated $217K.
  • Fayez Sarofim & Co first reported a position in MetLife in Q2 2021 and held it in 9 quarters.
  • Fayez Sarofim & Co's MetLife position peaked at $1.76M in Q2 2021.
  • 1,182 funds tracked by Wall St. Rank held MetLife as of Q3 2023.

Based on Fayez Sarofim & Co's 13F filing for Q3 2023, filed 15 Nov 2023.